Lupin Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 06:34 pm
06-11-2025 | 06:34 pm
Lupin's board met and approved Q2 & H1 consolidated results: Q2 net profit ₹1,484.13 Cr (EPS ₹32.36), revenue ₹7,047.51 Cr. Strategic moves include acquiring VISUfarma for €190M, divesting OTC/API R&D, and disbursing a ₹12/share dividend.
No comments yet. Be the first to comment!
